Suzhou Zelgen Biopharmaceuticals (ZLGN HK)

The company is an integrated biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative small-molecule and biologic therapies, with a strategic focus on oncology, autoimmune diseases, and hemostasis/hematology. Its business is powered by a dual innovation engine, which combines two proprietary technology platforms to build a diversified pipeline.